Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allogene Therapeutics (ALLO) Intangibles: 2019

Historic Intangibles for Allogene Therapeutics (ALLO) over the last 1 years, with Dec 2019 value amounting to $151,000.

  • Allogene Therapeutics' Intangibles was N/A to $151,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $151,000, marking a year-over-year change of. This contributed to the annual value of $151,000 for FY2019, which is N/A change from last year.
  • According to the latest figures from Q4 2019, Allogene Therapeutics' Intangibles is $151,000, which was down 49.83% from $301,000 recorded in Q3 2019.
  • In the past 5 years, Allogene Therapeutics' Intangibles ranged from a high of $603,000 in Q1 2019 and a low of $151,000 during Q4 2019.
  • Moreover, its 1-year median value for Intangibles was $376,500 (2019), whereas its average is $376,750.